These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12718718)

  • 1. ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
    Herrington DM; Howard TD
    Pharmacogenomics; 2003 May; 4(3):269-77. PubMed ID: 12718718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.
    Herrington DM; Howard TD; Hawkins GA; Reboussin DM; Xu J; Zheng SL; Brosnihan KB; Meyers DA; Bleecker ER
    N Engl J Med; 2002 Mar; 346(13):967-74. PubMed ID: 11919305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
    Albagha OM; McGuigan FE; Reid DM; Ralston SH
    J Bone Miner Res; 2001 Jan; 16(1):128-34. PubMed ID: 11149476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.
    Herrington DM; Howard TD; Brosnihan KB; McDonnell DP; Li X; Hawkins GA; Reboussin DM; Xu J; Zheng SL; Meyers DA; Bleecker ER
    Circulation; 2002 Apr; 105(16):1879-82. PubMed ID: 11997270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation of estrogen metabolism and the risks of cardiovascular disease.
    Almeida S; Hutz MH
    Curr Opin Investig Drugs; 2007 Oct; 8(10):814-20. PubMed ID: 17907057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor-alpha in pharmacogenetics of estrogen action.
    Herrington DM
    Curr Opin Lipidol; 2003 Apr; 14(2):145-50. PubMed ID: 12642782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
    J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor alpha polymorphic variants.
    Alevizaki M; Saltiki K; Cimponeriu A; Kanakakis I; Xita N; Alevizaki CC; Georgiou I; Sarika HL
    Eur J Endocrinol; 2007 Apr; 156(4):489-96. PubMed ID: 17389465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
    Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From presumed benefit to potential harm--hormone therapy and heart disease.
    Herrington DM; Howard TD
    N Engl J Med; 2003 Aug; 349(6):519-21. PubMed ID: 12904515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.